Chemelot leads €11m round for Fortimedix Surgical

All existing shareholders contributed to the round, including MKB Leningenfonds, an investment fund specialising in financing Dutch SMEs, and Rijksdient voor Ondernemend Nederland, a part of the Dutch Ministry of Economic Affairs.

Chemelot, which focuses on investing in smart materials and life sciences, has been an investor in parent group Fortimedix since 2004. Fortimedix Surgical span out of the wider group in 2012.

The round of funding will help the business launch its device FMX314, a single-port laparoscopy device. The launch is planned in the US this month, and in Europe in 2017.

Previous funding
In 2004, Fortimedix – Fortimedix Surgical's parent – received a venture round of an undisclosed amount from Limburg Ventures and NV Industriebank LIOF, a Maastricht-based investment bank providing early-stage venture investments. Chemelot invested in the company in the same year.

Company
Based in Nuth, the Netherlands, Fortimedix Surgical is a medical device company active within the field of minimally invasive surgery. The group was founded in 2012 as a subsidiary of parent group Fortimedix, specialised in endovascular stents.

The group has a subsidiary in San Diego, California.

People
Chemelot Ventures – Casper Bruens (managing director).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• Benelux
• Healthcare
• Benelux
• Netherlands
• Venture